Chester County News and Community Website
WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, this week announced the completion of patient enrollment in a clinical study evaluating the performance of …
Read More
MALVERN, PA — Vesper Medical, Inc., a developer of medical devices for deep venous disease, announced initiation of its U.S. Food and Drug Administration (FDA) Investigational Exemption (IDE) study – …
Read More
COATESVILLE, PA — Brandywine Hospital – Tower Health is reminding community members to call 9-1-1 if they are experiencing symptoms of heart attack. EMS can begin the immediate life-saving care …
Read More
COATESVILLE, PA — Brandywine Hospital–Tower Health has received the Mission: Lifeline® Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the …
Read More
WEST CHESTER, PA — Once again, Chester County Hospital has received the Mission: Lifeline® Gold Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association …
Read More
MALVERN, PA — XyloCor Therapeutics recently announced it has successfully dosed the first two patients in the EXACT Trial, a Phase 1/2 dose escalation trial evaluating the safety, tolerability and …
Read More
WAYNE, PA — Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive one-year results from its Tack Optimized Balloon Angioplasty (TOBA) II BTK clinical trial during …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, announced the first patient enrollment in a clinical study that will evaluate the performance of Teleflex …
Read More WAYNE, PA — Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, recently announced the peer-reviewed publication of its Tack Optimized Balloon Angioplasty (TOBA) III 12-month clinical trial …
Read More
WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK Study.
Read More